{"protocolSection":{"identificationModule":{"nctId":"NCT02483169","orgStudyIdInfo":{"id":"PICASSO-IMT"},"organization":{"fullName":"Asan Medical Center","class":"OTHER"},"briefTitle":"PreventIon of IMT Progression in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage-IMT Study","officialTitle":"Double Blind Placebo Controlled Multicenter Trial for Prevention of IMT Progression in the Ischemic Stroke Patients With High Risk of Cerebral Hemorrhage With Cilostazol and Probucol","acronym":"PICASSO-IMT"},"statusModule":{"statusVerifiedDate":"2015-12","overallStatus":"UNKNOWN","lastKnownStatus":"ACTIVE_NOT_RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2009-06"},"primaryCompletionDateStruct":{"date":"2016-09","type":"ESTIMATED"},"completionDateStruct":{"date":"2016-12","type":"ESTIMATED"},"studyFirstSubmitDate":"2015-06-24","studyFirstSubmitQcDate":"2015-06-25","studyFirstPostDateStruct":{"date":"2015-06-26","type":"ESTIMATED"},"lastUpdateSubmitDate":"2015-12-23","lastUpdatePostDateStruct":{"date":"2015-12-24","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Sun U. Kwon","investigatorTitle":"Professor","investigatorAffiliation":"Asan Medical Center"},"leadSponsor":{"name":"Asan Medical Center","class":"OTHER"},"collaborators":[{"name":"Korea Otsuka Pharmaceutical Co., Ltd.","class":"INDUSTRY"}]},"oversightModule":{"oversightHasDmc":true},"descriptionModule":{"briefSummary":"Through this study, the investigators are to prove that Cilostazol effectively prevent progression of intima-medial thickness in ischemic stroke patients with high risk of cerebral hemorrhage, along with no significant increase in the risk of occurrence of hemorrhagic side effects.\n\nThe primary hypothesis of this study is; Cilostazol alone or with probucol will reduce the progression of intima-medial thickness compared to aspirin in the ischemic stroke patients with symptomatic or asymptomatic old cerebral hemorrhage."},"conditionsModule":{"conditions":["Brain Ischemia","Intracranial Hemorrhages"],"keywords":["ischemic stroke","intracranial hemorrhage","cilostazol","probucol","intima media thickness"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE4"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"FACTORIAL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"QUADRUPLE","whoMasked":["PARTICIPANT","CARE_PROVIDER","INVESTIGATOR","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":800,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Cilostazol+ Probucol","type":"EXPERIMENTAL","description":"100mg cilostazol bid plus probucol plus placebo of aspirin","interventionNames":["Drug: cilostazol","Drug: Probucol","Drug: Placebo of aspirin","Device: Intima-medial thickness"]},{"label":"Aspirin + Probucol","type":"ACTIVE_COMPARATOR","description":"aspirin plus placebo cilostazol plus probucol","interventionNames":["Drug: Probucol","Drug: Aspirin","Drug: placebo of cilostazol","Device: Intima-medial thickness"]},{"label":"Cilostazol","type":"EXPERIMENTAL","description":"cilostazol plus placebo of aspirin","interventionNames":["Drug: cilostazol","Drug: Placebo of aspirin","Device: Intima-medial thickness"]},{"label":"Aspirin","type":"ACTIVE_COMPARATOR","description":"aspirin plus placebo of cilostazol","interventionNames":["Drug: Aspirin","Drug: placebo of cilostazol","Device: Intima-medial thickness"]}],"interventions":[{"type":"DRUG","name":"cilostazol","description":"Cilostazol 100mg bid","armGroupLabels":["Cilostazol","Cilostazol+ Probucol"],"otherNames":["Pletaal produced by Korea Otsuka Pharmaceutical company"]},{"type":"DRUG","name":"Probucol","description":"Probucol 250mg bid","armGroupLabels":["Aspirin + Probucol","Cilostazol+ Probucol"],"otherNames":["Probucol is produced by Otsuka Pharmaceutical"]},{"type":"DRUG","name":"Aspirin","description":"Aspirin 100mg qd","armGroupLabels":["Aspirin","Aspirin + Probucol"]},{"type":"DRUG","name":"placebo of cilostazol","description":"same shape and size of active cilostazol","armGroupLabels":["Aspirin","Aspirin + Probucol"]},{"type":"DRUG","name":"Placebo of aspirin","description":"same size and shape of active aspirin 100mg","armGroupLabels":["Cilostazol","Cilostazol+ Probucol"]},{"type":"DEVICE","name":"Intima-medial thickness","description":"ultrasound measured IMT of both common carotid arteries","armGroupLabels":["Aspirin","Aspirin + Probucol","Cilostazol","Cilostazol+ Probucol"],"otherNames":["- Annualized change of mean and maximum common carotid intima-medial thickness","- Annualized change of carotid plaque score"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"mean carotid IMT progression","description":"Annualized rate of change in mean common carotid intimal-medial thickness","timeFrame":"one year"}],"secondaryOutcomes":[{"measure":"maximum carotid IMT progression","description":"annualized rate of change in maximal carotid intimal-medial thickness","timeFrame":"one year"},{"measure":"carotid plaque score","description":"annualized change of carotid plaque score","timeFrame":"one year"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Clinical diagnosis of ischemic stroke within 120 days\n* Adult aged 20 years or older\n* High risk of hemorrhagic stroke (history of intracranial hemorrhage or imaging evidence of previous intracranial hemorrhage)\n* Informed consent\n\nExclusion Criteria:\n\n* Clinical diagnosis of myocardial infarction or coronary intervention within 4 weeks\n* Bleeding tendency\n* Pregnant or breast-feeding woman\n* Hemorrhagic stroke within 6 months\n* Patient who was taking antithrombotic medication other than aspirin and does not agree to change the previous medication\n* Severe cardiovascular disease such as cardiomyopathy or congestive heart failure\n* Life expectancy less than one year\n* Contraindication to long term aspirin use\n* Enrolled in other clinical trial within 30 days","healthyVolunteers":false,"sex":"ALL","minimumAge":"20 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Sun U Kwon, MD,PhD","affiliation":"Department of Neurology, Asan Medical Center","role":"PRINCIPAL_INVESTIGATOR"}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000083242","term":"Ischemic Stroke"},{"id":"D000020300","term":"Intracranial Hemorrhages"},{"id":"D000002543","term":"Cerebral Hemorrhage"},{"id":"D000002545","term":"Brain Ischemia"},{"id":"D000007511","term":"Ischemia"},{"id":"D000006470","term":"Hemorrhage"}],"ancestors":[{"id":"D000020521","term":"Stroke"},{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000010335","term":"Pathologic Processes"}],"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M9246","name":"Hemorrhage","asFound":"Hemorrhage","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","asFound":"Ischemia","relevance":"HIGH"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M5482","name":"Cerebral Hemorrhage","asFound":"Cerebral Hemorrhage","relevance":"HIGH"},{"id":"M5484","name":"Brain Ischemia","asFound":"Brain Ischemia","relevance":"HIGH"},{"id":"M20249","name":"Disease Progression","relevance":"LOW"},{"id":"M21803","name":"Intracranial Hemorrhages","asFound":"Intracranial Hemorrhage","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"}]},"interventionBrowseModule":{"meshes":[{"id":"D000001241","term":"Aspirin"},{"id":"D000077407","term":"Cilostazol"},{"id":"D000011341","term":"Probucol"}],"ancestors":[{"id":"D000000894","term":"Anti-Inflammatory Agents, Non-Steroidal"},{"id":"D000018712","term":"Analgesics, Non-Narcotic"},{"id":"D000000700","term":"Analgesics"},{"id":"D000018689","term":"Sensory System Agents"},{"id":"D000018373","term":"Peripheral Nervous System Agents"},{"id":"D000045505","term":"Physiological Effects of Drugs"},{"id":"D000000893","term":"Anti-Inflammatory Agents"},{"id":"D000018501","term":"Antirheumatic Agents"},{"id":"D000005343","term":"Fibrinolytic Agents"},{"id":"D000050299","term":"Fibrin Modulating Agents"},{"id":"D000045504","term":"Molecular Mechanisms of Pharmacological Action"},{"id":"D000010975","term":"Platelet Aggregation Inhibitors"},{"id":"D000016861","term":"Cyclooxygenase Inhibitors"},{"id":"D000004791","term":"Enzyme Inhibitors"},{"id":"D000058633","term":"Antipyretics"},{"id":"D000001993","term":"Bronchodilator Agents"},{"id":"D000001337","term":"Autonomic Agents"},{"id":"D000018927","term":"Anti-Asthmatic Agents"},{"id":"D000019141","term":"Respiratory System Agents"},{"id":"D000014665","term":"Vasodilator Agents"},{"id":"D000018696","term":"Neuroprotective Agents"},{"id":"D000020011","term":"Protective Agents"},{"id":"D000058987","term":"Phosphodiesterase 3 Inhibitors"},{"id":"D000010726","term":"Phosphodiesterase Inhibitors"},{"id":"D000000924","term":"Anticholesteremic Agents"},{"id":"D000000960","term":"Hypolipidemic Agents"},{"id":"D000000963","term":"Antimetabolites"},{"id":"D000057847","term":"Lipid Regulating Agents"},{"id":"D000000975","term":"Antioxidants"}],"browseLeaves":[{"id":"M4238","name":"Aspirin","asFound":"Knee","relevance":"HIGH"},{"id":"M1788","name":"Cilostazol","asFound":"Stored","relevance":"HIGH"},{"id":"M13904","name":"Probucol","asFound":"Transfused","relevance":"HIGH"},{"id":"M3907","name":"Anti-Inflammatory Agents","relevance":"LOW"},{"id":"M3908","name":"Anti-Inflammatory Agents, Non-Steroidal","relevance":"LOW"},{"id":"M3722","name":"Analgesics","relevance":"LOW"},{"id":"M20476","name":"Analgesics, Non-Narcotic","relevance":"LOW"},{"id":"M20294","name":"Antirheumatic Agents","relevance":"LOW"},{"id":"M8163","name":"Fibrinolytic Agents","relevance":"LOW"},{"id":"M13555","name":"Platelet Aggregation Inhibitors","relevance":"LOW"},{"id":"M18899","name":"Cyclooxygenase Inhibitors","relevance":"LOW"},{"id":"M7641","name":"Enzyme Inhibitors","relevance":"LOW"},{"id":"M28866","name":"Antipyretics","relevance":"LOW"},{"id":"M4959","name":"Bronchodilator Agents","relevance":"LOW"},{"id":"M20653","name":"Anti-Asthmatic Agents","relevance":"LOW"},{"id":"M20827","name":"Respiratory System Agents","relevance":"LOW"},{"id":"M17102","name":"Vasodilator Agents","relevance":"LOW"},{"id":"M20463","name":"Neuroprotective Agents","relevance":"LOW"},{"id":"M21559","name":"Protective Agents","relevance":"LOW"},{"id":"M29023","name":"Phosphodiesterase 3 Inhibitors","relevance":"LOW"},{"id":"M13319","name":"Phosphodiesterase Inhibitors","relevance":"LOW"},{"id":"M3933","name":"Anticholesteremic Agents","relevance":"LOW"},{"id":"M3968","name":"Hypolipidemic Agents","relevance":"LOW"},{"id":"M3971","name":"Antimetabolites","relevance":"LOW"},{"id":"M28573","name":"Lipid Regulating Agents","relevance":"LOW"},{"id":"M3982","name":"Antioxidants","relevance":"LOW"}],"browseBranches":[{"abbrev":"Antipy","name":"Antipyretics"},{"abbrev":"Infl","name":"Anti-Inflammatory Agents"},{"abbrev":"ARhu","name":"Antirheumatic Agents"},{"abbrev":"FiAg","name":"Fibrinolytic Agents"},{"abbrev":"Analg","name":"Analgesics"},{"abbrev":"PlAggInh","name":"Platelet Aggregation Inhibitors"},{"abbrev":"All","name":"All Drugs and Chemicals"},{"abbrev":"VaDiAg","name":"Vasodilator Agents"},{"abbrev":"NeuroAg","name":"Neuroprotective Agents"},{"abbrev":"Resp","name":"Respiratory System Agents"},{"abbrev":"Lipd","name":"Lipid Regulating Agents"}]}},"hasResults":false}